Bococizumab is a cutting-edge anti-PCSK9 antibody specifically developed to address hypercholesterolemia. This therapeutic agent functions through the PCSK9 protein, a critical regulator of cholesterol amounts. By https://ztndz.com/story27959558/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia